financetom
Business
financetom
/
Business
/
MP Materials commences $500 million public offering of common stock
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MP Materials commences $500 million public offering of common stock
Jul 16, 2025 2:59 PM

July 16 (Reuters) - MP Materials ( MP ) said on

Wednesday it would sell $500 million of its common stock, a day

after the U.S. rare earths miner inked a supply deal with Apple ( AAPL )

.

Shares of MP Materials ( MP ) fell 5.8% in extended trade. They

have surged 275% so far this year, giving the company a market

value of $9.57 billion.

The $500 million agreement with Apple ( AAPL ) is a coup for MP and a

rare investment by a tech company aiming to reduce its supply

risks for rare earth magnets.

The Las Vegas-based company also signed a

multibillion-dollar agreement with the U.S. Department of

Defense last week as the government seeks to reduce its reliance

on China, which restricted rare earths exports in April in

response to President Donald Trump's tariffs. Though the U.S.

and China reached a deal in June that has resolved much of the

rare earths dispute, broader trade tensions continue to

underscore demand for non-Chinese supply.

The Pentagon deal did not require MP Materials ( MP ) to issue

stock for the general public.

MP said it intends to use net proceeds from the offering to

fund growth opportunities and for general corporate

purposes.

The company said it would grant underwriters a 30-day option

to purchase up to an additional 15% of its shares.

J.P. Morgan and Goldman Sachs are acting as lead joint

book-running managers in the stock sale, while Morgan Stanley is

another book-running manager.

(Reporting by Sumit Saha in Bengaluru; Editing by Devika

Syamnath)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sana Biotechnology's SC291 Gets FDA Fast Track Designation for Systemic Lupus Erythematosus
Sana Biotechnology's SC291 Gets FDA Fast Track Designation for Systemic Lupus Erythematosus
Dec 2, 2024
09:41 AM EST, 12/02/2024 (MT Newswires) -- Sana Biotechnology ( SANA ) said Monday that the US Food and Drug Administration has granted fast track designation to its SC291 CAR T cell therapy product candidate for the treatment of relapsed/refractory systemic lupus erythematosus. The company said the designation is designed to facilitate the development and expedite the regulatory review process...
AirBaltic stalls IPO until at least the first half of 2025
AirBaltic stalls IPO until at least the first half of 2025
Dec 2, 2024
LONDON, Dec 2 (Reuters) - AirBaltic is pushing its planned initial public offering back to the first half of 2025 or later as its advisers suggest waiting for improved market conditions in the European sector. The Latvian airline, which had previously said it would consider an IPO in the second half of 2024, will instead look to do it if...
Nasdaq Updates Swedish Stock Exchange's Dual US Listing Rules
Nasdaq Updates Swedish Stock Exchange's Dual US Listing Rules
Dec 2, 2024
09:43 AM EST, 12/02/2024 (MT Newswires) -- Nasdaq (NDAQ) said Monday that it has updated the rulebook for its Nasdaq Stockholm Main Market, effective Jan. 1 The market operator said the update is intended to streamline the listing review process for companies that want to list on Nasdaq in Sweden as well as in the US. Nasdaq said the update...
News Corp's Dow Jones Acquires WorldECR
News Corp's Dow Jones Acquires WorldECR
Dec 2, 2024
09:44 AM EST, 12/02/2024 (MT Newswires) -- News Corp's ( NWSA ) Dow Jones unit said Monday it has acquired WorldECR, a London-based provider of news, data and analysis on global export control and trade sanctions. Financial details of the acquisition weren't disclosed. Dow Jones said WorldECR will enhance its existing product portfolio as part of Dow Jones Risk &...
Copyright 2023-2026 - www.financetom.com All Rights Reserved